LFCR

MKT CAP:$184M

Lifecore Biomedical, Inc.

Market Cap

$184M

Healthcare·Drug Manufacturers - Specialty & Generic·🇺🇸 United States·NASDAQ

Healthcare·Drug·🇺🇸·NASDAQ

Stock Price

$5.03-$2.71 (-35.08%)

Apr 23, 2026

Company Details

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States and internationally. It operates through Lifecore, Curation Foods, and Other segme...

CEO

Paul Josephs

IPO Date

Feb 15, 1996

Website

www.lifecore.com

Key Metrics TTM

Revenue

$147M

+12.4% YoY

Net Income

-$34M

EPS (Diluted)

-$1.07

Free Cash Flow

$3M

Revenue / Share

$3.93

Gross Margin

32.3%

Operating Margin

-3.0%

Net Margin

-23.0%

FCF Margin

1.8%

P/S

1.3x

P/E

—

Earnings Reports

Q3 2026

May 5, 2026

PENDING

Q2 2026

Mar 16, 2026

$44M+36.4%EPS -$0.25

Q1 2026

Nov 6, 2025

$31M+25.9%EPS -$0.29

FY 2025

Aug 7, 2025

$129M+0.5%EPS -$1.27

Q4 2025

Aug 7, 2025

$36M-3.8%EPS -$0.06

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q3 21	$45M	$14M	$2M
Q4 21	$140M	$25M	$1M
Q1 22	$42M	$10M	-$3M
Q2 22	$43M	$15M	$4M
Q4 22	$48M	$11M	-$39M
Q4 23	$26M	$8M	-$1M
Q1 24	$25M	$3M	-$9M
Q2 24	$30M	$10M	-$1M
Q3 24	$36M	$12M	-$895.0K
Q4 24	$38M	$17M	$2M
Q1 25	$25M	$5M	-$12M
Q2 25	$33M	$11M	-$2M
Q3 25	$35M	$10M	-$9M
Q4 25	$36M	$14M	$5M
Q1 26	$31M	$8M	-$3M
Q2 26	$44M	$16M	$2M

Valuation

Quarter	P/S	P/E
Q3 21	0.7x	—
Q4 21	0.8x	—
Q1 22	0.9x	—
Q2 22	0.9x	—
Q4 22	1.0x	—
Q4 23	1.0x	—
Q1 24	1.8x	—
Q2 24	1.7x	—
Q3 24	2.2x	—
Q4 24	1.4x	15.0x
Q1 25	1.5x	29.6x
Q2 25	1.8x	—
Q3 25	1.5x	—
Q4 25	1.9x	—
Q1 26	2.0x	—
Q2 26	2.1x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q3 21	-$8M	-$12M
Q4 21	$4M	-$8M
Q1 22	$831.0K	-$7M
Q2 22	-$5M	-$10M
Q4 22	$36.0K	-$10M
Q4 23	-$272.0K	-$9M
Q1 24	-$8M	-$13M
Q2 24	$1M	-$3M
Q3 24	-$1M	-$8M
Q4 24	$9M	$6M
Q1 25	-$643.0K	-$4M
Q2 25	-$6M	-$9M
Q3 25	$1M	-$4M
Q4 25	$5M	$3M
Q1 26	$2M	$25.0K
Q2 26	$6M	$4M

Capital Expenditures

Quarter	CapEx
Q3 21	$4M
Q4 21	$12M
Q1 22	$8M
Q2 22	$5M
Q4 22	$10M
Q4 23	$9M
Q1 24	$5M
Q2 24	$4M
Q3 24	$6M
Q4 24	$3M
Q1 25	$3M
Q2 25	$2M
Q3 25	$5M
Q4 25	$2M
Q1 26	$2M
Q2 26	$2M

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q3 21	-70.8%	-74.8%
Q4 21	-10.4%	-18.1%
Q1 22	-69.3%	-70.0%
Q2 22	-66.8%	-70.3%
Q4 22	+6.6%	+104.9%
Q4 23	-81.7%	-80.7%
Q1 24	-41.1%	-25.3%
Q2 24	-30.6%	-19.5%
Q3 24	-25.0%	-57.7%
Q4 24	+48.5%	+33.6%
Q1 25	+0.7%	+9.5%
Q2 25	+8.0%	+9.1%
Q3 25	-1.5%	+20.7%
Q4 25	-3.8%	-12.9%
Q1 26	+25.9%	-5.8%
Q2 26	+36.4%	+21.9%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q3 21	$797.0K	1.8%
Q4 21	$776.0K	0.6%
Q1 22	$620.0K	1.5%
Q2 22	$686.0K	1.6%
Q4 22	$680.0K	1.4%
Q4 23	$816.0K	3.2%
Q1 24	$2M	6.3%
Q2 24	$2M	5.2%
Q3 24	$1M	4.2%
Q4 24	$2M	4.2%
Q1 25	$2M	9.8%
Q2 25	$3M	10.4%
Q3 25	$0	0.0%
Q4 25	$2M	5.0%
Q1 26	$2M	7.7%
Q2 26	$0	0.0%

OpEx Breakdown

Quarter	R&D	SG&A
Q3 21	$2M	$8M
Q4 21	$3M	$16M
Q1 22	$2M	$9M
Q2 22	$2M	$8M
Q4 22	$2M	$19M
Q4 23	$3M	$8M
Q1 24	$2M	$9M
Q2 24	$2M	$9M
Q3 24	$2M	$10M
Q4 24	$2M	$12M
Q1 25	$2M	$14M
Q2 25	$2M	$11M
Q3 25	$2M	$10M
Q4 25	$2M	$9M
Q1 26	$2M	$9M
Q2 26	$2M	$8M

War Chest

Quarter	Cash	Short-term Investments	Total
Q3 22	$2M	$0	$2M
Q4 22	$991.0K	$0	$991.0K
Q1 23	$4M	$0	$4M
Q2 23	$7M	$0	$7M
Q3 23	$3M	$0	$3M
Q4 23	$19M	$0	$19M
Q1 24	$9M	$0	$9M
Q2 24	$3M	$0	$3M
Q3 24	$3M	$0	$3M
Q4 24	$8M	$0	$8M
Q1 25	$6M	$0	$6M
Q2 25	$9M	$0	$9M
Q3 25	$5M	$0	$5M
Q4 25	$8M	$0	$8M
Q1 26	$19M	$0	$19M
Q2 26	$17M	$0	$17M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q3 21	29M	+0.1%	+0.5%
Q4 21	29M	+0.0%	+0.4%
Q1 22	29M	+0.3%	+0.6%
Q2 22	29M	+0.2%	+0.7%
Q4 22	30M	+0.1%	+0.6%
Q4 23	30M	+2.7%	+3.4%
Q1 24	30M	+0.3%	+3.3%
Q2 24	36M	+19.8%	+23.6%
Q3 24	37M	+0.5%	+24.0%
Q4 24	31M	-16.5%	+0.8%
Q1 25	31M	+1.0%	+1.5%
Q2 25	34M	+11.4%	-5.7%
Q3 25	37M	+7.7%	+1.1%
Q4 25	37M	+0.0%	+21.1%
Q1 26	37M	+1.0%	+21.2%
Q2 26	37M	+0.2%	+9.1%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q3 21	—	—
Q4 21	—	—
Q1 22	—	—
Q2 22	—	—
Q4 22	—	—
Q4 23	$55.6K	459
Q1 24	$53.4K	459
Q2 24	$65.7K	459
Q3 24	$77.8K	459
Q4 24	$72.3K	524
Q1 25	$47.1K	524
Q2 25	$62.1K	524
Q3 25	$67.1K	524
Q4 25	$89.8K	406
Q1 26	$76.6K	406
Q2 26	$109.4K	406

Revenue / Employee